---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-310315"
form_type: "8-K"
ticker: "RNTX"
cik: "0001420565"
company_name: "Rein Therapeutics, Inc."
filed_at: "2026-07-21T20:10:17+00:00"
generated_at: "2026-07-21T20:11:07.129386+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Rein Therapeutics stockholders approve increase in authorized shares to 200M, re-elect directors

## Summary
- Elected Josef H. von Rickenbach and Reinhard J. Ambros as Class III directors.
- Approved amendment to increase authorized common shares from 100M to 200M (61.0M for, 2.4M against).
- Ratified CBIZ CPAs P.C. as independent auditor for FY2026 (62.95M for, 0.17M against).
- Advisory say-on-pay approved with 37.6M for, 0.9M against, 25.1M broker non-votes.

## SEC filing metadata
- accession: 0001193125-26-310315
- form_type: 8-K
- ticker: RNTX
- cik: 0001420565
- company_name: Rein Therapeutics, Inc.
- filed_at: 2026-07-21T20:10:17+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1420565/000119312526310315/0001193125-26-310315-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1420565/000119312526310315/d89210d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-310315
- JSON: https://secwatch.observer/filing/0001193125-26-310315.json
- Plain text: https://secwatch.observer/filing/0001193125-26-310315.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.